On September 16, 2019, we received a Bid Price Deficiency Notice (the “Notice”) from OTC Markets Group that the bid price of our common stock had closed below $0.01 for more than 30 consecutive calendar days and thus no longer met the Standards for Continued Eligibility for OTCQB as per the OTCQB Standards Section 2.3(2). The Notice stated that, pursuant to Section 4.1 of the OTCQB Standards, we were granted a cure period of 90 calendar days (until December 15, 2019) during which the minimum closing bid price for our common stock must be $0.01 or greater for ten consecutive trading days in order to continue trading on the OTCQB marketplace. On November 7, 2019, the Company’s cure period was extended until February 5, 2020. If this requirement is not met by the end of the cure period, our securities will be removed from the OTCQB marketplace.